tirzepatide lily Eli Lilly's scores again, this time in 2 sleep apnea trials Mounjaro® (tirzepatide) injection and Zepbound®

doi:10.1212/WNL.0000000000010250 49

Importantly, Zepbound carries a boxed warning regarding the risk of thyroid C-cell tumors and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN2)

This conservative therapy can reduce circumference by approximately 10% and improve pain and symptoms of hypersensitivity to pressure

The therapy must target the multi-pathological process involved with MetS, with each disorder component being recognized and aggressively treated (47)

Other states may only cover these medications for the obstructive sleep apnea indication or require step therapy